abstract |
The present disclosure relates to therapeutic methods or agents for compounds, pharmaceutical compositions containing such compounds, and specific neurological disorders associated with, but not limited to, inflammatory signaling processes of inflammatory diseases and, but not limited to, misfolded proteins. With respect to the use of such compounds. [Selection diagram] None |